Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Colonic bacterial composition in Parkinson's disease
2015 Standout
Microbiota in health and diseases
2022 Standout
Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
2009
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Autoimmune liver disease: overlap and outliers
2007
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease
2009
Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes
2011
Lung Cancer
2008 Standout
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
2011
Are infectious agents involved in primary biliary cirrhosis? A PCR approach
1999
Epidemiology and risk factors for IBD
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis
2011
Ulcerative colitis
2012 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Gut microbiome alterations in Alzheimer’s disease
2017 Standout
Prevalence and specificity of LKB1 genetic alterations in lung cancers
2007
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
2010
Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone
2013
Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease
2008
Helicobacters and Extragastric Diseases
2009
Infectome: A platform to trace infectious triggers of autoimmunity
2012
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
2016 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis
2008
Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial
2012
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases
2019 Standout
Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs
2014
Primary Biliary Cirrhosis
2011 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Recent developments in understanding the role of the gut microbiota in brain health and disease
2017
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
2014
Antimicrobial Surveillance in Idiopathic Parkinsonism: Indication‐Specific Improvement in Hypokinesia Following H elicobacter pylori Eradication and Non‐Specific Effect of Antimicrobials for Other Indications in Worsening Rigidity
2013
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of John O’Donohue being referenced
Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome
2005
Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis
2002
Helicobacter Hypothesis for Idiopathic Parkinsonism: Before and Beyond
2008
Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease
2004
Antibodies to atypical mycobacteria in primary biliary cirrhosis
1994
Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis
1998
Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse
2008